03 Aug 2020
Posted in Pharma
Iran is experiencing higher fatality rate during second surge due to healthcare and welfare inequalities, says GlobalData
Since early May, there has been a second surge of the COVID-19 pandemic in Iran. In comparison to other countries, the number of daily deaths during the second surge is considerably higher than in the first surge as a result of prolonged pressure on the health system along with inequalities in healthcare access and social security, says GlobalData, a leading data and analytics company.
Bahram Hassanpourfard, MPH, Epidemiologist at GlobalData, comments: “Countries with high inequalities in their healthcare and welfare systems will see a higher fatality rate during the second surge. The Iranian Government lifted lockdown measures too early, causing the virus to spread further in the country. New cases in Iran shifted from the central provinces to poorer and more remote regions. Now the pandemic has spread to every corner of the country.”
Iran has exhausted its healthcare system since February, and the virus has shifted to remote areas where hospital beds are limited and resources are scarce, resulting in a higher fatality rate than the first wave.
Hassanpourfard concludes: “This has been compounded by the lack of social security and inequalities in wealth distribution, forcing the elderly and vulnerable people to work in high-risk environments. GlobalData epidemiologists predict an unstable and increasing number of daily confirmed deaths in Iran.”